AXSM (Axsome Therapeutics, Inc.) — AI Stock Analysis & Recommendation
Research of October 14, 2026 · Healthcare / Pharmaceutical Preparations
TradeFlare's AI research teams rate AXSM a BUY. The latest price is $156.32.
The research plan
- Entry: $174.76
- Target: $188.00
- Stop: $152.50
AXSM at a glance
| Market value | $9.4B |
| Revenue growth (year over year) | 56.9% |
| Profit margin | -24.7% |
| Debt / equity | 1.42 |
TradeFlare's published calls on AXSM
- February 24, 2026: hit stop, -12.7%
Every AI call on AXSM since June 3, 2026, and what happened next (1 calls) →
Frequently asked questions
Is AXSM a buy? In its research of October 14, 2026, TradeFlare's AI rated AXSM a BUY. This is AI-generated research, not financial advice.
What is the price target for AXSM? The research sets a target of $188.00 with a stop at $152.50.
How have TradeFlare's past calls on AXSM done? 1 published signal(s), listed above. Every result, win or loss, stays on the public record.
When was this analysis last updated? October 14, 2026. Stocks on TradeFlare's lists are re-researched every market night. How the research works.
Research of October 14, 2026 · AI-generated analysis for educational purposes, can be wrong, not financial advice.